MELBOURNE, Australia--(BUSINESS WIRE)--Nov. 14, 2005--Genetic Technologies Limited (“GTG”) (NASDAQ:GENE) (ASX:GTG) announced that as reported on November 3, 2005, the United States District Court, Northern District of California had posted on its website a Stipulated Revised Case Schedule and Order (the “Order”) in respect of GTG’s patent dispute with Applera Corporation.
